Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Burning Rock Biotech Q1 EPS $(0.26) Up From $(0.39) YoY, Sales $20.75M Down From $21.38M YoY

Author: Benzinga Newsdesk | May 30, 2023 05:37am
Burning Rock Biotech (NASDAQ:BNR) reported quarterly losses of $(0.26) per share. This is a 33.33 percent increase over losses of $(0.39) per share from the same period last year. The company reported $20.75 million in sales this quarter. This is a 2.94 percent decrease over sales of $21.38 million the same period last year.

Posted In: BNR


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist